Differentiation Therapy and Advances in Leukemia

We are pleased to announce Cold Spring Harbor Asia/The 13th International Conference on Differentiation Therapy: Differentiation Therapy and Advances in Cancer which will be held at the Suzhou Dushu Lake Conference Center in Suzhou, China, located approximately 60 miles west of Shanghai. This conference will begin in the afternoon of Saturday October 20, and will conclude after lunch on wednesday Oct 24, 2012.

The biennial International Conference on Differentiation Therapy (ICDT) has been recognized as one of the highest-level international scientific meetings in the field of cancer research. Differentiation therapy, which has already shown a targeted, cancer selective therapeutic effect that turned acute promyelocytic leukemia from highly fatal to curable, represents a breakthrough in cancer therapies. The ICDT conference is arranged to reflect the most updated advancement in differentiation cancer therapies. We will also select short talks from openly submitted abstracts and organize workshops pertinent to the subjects of the conference to ensure the maximum amount of interaction and discussion between lecturers and participants.

Major Topics:
- Epigenetics and Epigenomics
– mechanism and impact on cancer therapy
- Genetics and Genomics of Cancer
- Cancer stem cells and novel targets
- Animal models and novel targets
- Targeted Therapies: Present and Future
- Differentiation Therapy of APL and Beyond
+ show speakers and program
Keynote Speakers:
Zhu Chen, Ministry of Health P.R. China/Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, CHINA
Abstract title: TBA

Invited Speakers:
Saijuan Chen, Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, CHINA
Abstract title: TBA
Riccardo Dalla-Favera, Columbia University, USA
Abstract title: TBA
Hughes De The, CNRS Hospital St. Louis, FRANCE
Abstract title: TBA
Scott Hiebert, Vanderbilt University, USA
Abstract title: TBA
Phillip Koeffler, National University of Singapore, SINGAPORE
Abstract title: TBA
Tomoki Naoe, Nagoya University Graduate School of Medicine, JAPAN
Abstract title: The efficacy and safety of a series of treatment from arsenic trioxide therapy to autologous transplantation for relapsed APL patients: a prospective JALSG APL205R study
Yang Shi, Children's Hospital Boston & Harvard Medical School, USA
Abstract title: TBA
Martin Tallman, New York-Presbyterian Hospital/Weill Cornell Medical Center, USA
Abstract title: Seminal Observations from North American Intergroup Trials in APL
Daniel Tenen, Harvard Medical School, USA
Abstract title: TBA
Samuel Waxman, The Mount Sinai Medical School, USA
Abstract title: TBA
Arthur Zelent, Institute of Cancer Research, UK
Abstract title: Unlocking retinoic acid induced differentiation response in AML

20 Oct - 24 Oct 2012
Suzhou Dushu Lake
China
meeting website